Inter-ictal assay of peripheral circulating inflammatory mediators in migraine patients under adjunctive cervical non-invasive vagus nerve stimulation (nVNS): A proof-of-concept study.


Journal

Brain stimulation
ISSN: 1876-4754
Titre abrégé: Brain Stimul
Pays: United States
ID NLM: 101465726

Informations de publication

Date de publication:
Historique:
received: 14 11 2018
revised: 31 12 2018
accepted: 16 01 2019
pubmed: 13 2 2019
medline: 13 7 2019
entrez: 13 2 2019
Statut: ppublish

Résumé

To assay peripheral inter-ictal cytokine serum levels and possible relations with non-invasive vagus nerve stimulation (nVNS) responsiveness in migraineurs. This double-blinded, sham-controlled study enrolled 48 subjects and measured headache severity, frequency [headache days/month, number of total and mild/moderate/severe classified attacks/month], functional state [sleep, mood, body weight, migraine-associated disability] and serum levels of inflammatory markers [inter-ictal] using enzyme-linked immunoassays at baseline and after 2 months of adjunctive nVNS compared to sham stimulation and suitably matched controls. No significant differences were observed at baseline and after 2 months for headache severity, total attacks/month, headache days/month and functional outcome [sleep, mood, disability] between verum and sham nVNS. However, the number of severe attacks/month significantly decreased in the verum nVNS group and circulating pro-inflammatory IL-1β was elevated significantly in the sham group compared to nVNS. Levels of anti-inflammatory IL-10 were significantly higher at baseline in both groups compared to healthy controls, but not at 2 months follow-up [p < 0.05]. Concentrations of high-mobility group box-1 (HMGB-1), IL-6, tumor-necrosis factor-α (TNF-α), leptin, adiponectin, ghrelin remained unchanged [p > 0.05]. No severe device-/stimulation-related adverse events occurred. 2 months of adjunctive cervical nVNS significantly declined the number of severe attacks/month. Pro-inflammatory IL-1β plasma levels [inter-ictal] were higher in sham-treated migraine patients compared to verum nVNS. However, pro- [IL-6, HMGB-1, TNF-α, leptin] and anti-inflammatory [IL-10, adiponectin, ghrelin] mediators did not differ statistically. Profiling of neuroinflammatory circuits in migraine to predict nVNS responsiveness remains an experimental approach, which may be biased by pre-analytic variables warranting large-scale biobank-based systematic investigations [omics].

Identifiants

pubmed: 30745260
pii: S1935-861X(19)30039-7
doi: 10.1016/j.brs.2019.01.008
pii:
doi:

Substances chimiques

Cytokines 0

Banques de données

DRKS
['DRKS00009944']

Types de publication

Controlled Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

643-651

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Shafqat R Chaudhry (SR)

Department of Neurosurgery, Bonn, Germany; University Hospital Bonn, Rheinische Friedrich-Wilhelms-University of Bonn, Germany.

Ilana S Lendvai (IS)

Department of Neurosurgery, Bonn, Germany; University Hospital Bonn, Rheinische Friedrich-Wilhelms-University of Bonn, Germany.

Sajjad Muhammad (S)

Department of Neurosurgery, Bonn, Germany; Helsinki University Hospital, Helsinki, Finland.

Philipp Westhofen (P)

Center for Hemostaseology and Transfusion Medicine, Bonn, Germany.

Johannes Kruppenbacher (J)

Center for Hemostaseology and Transfusion Medicine, Bonn, Germany.

Lukas Scheef (L)

University Hospital Bonn, Rheinische Friedrich-Wilhelms-University of Bonn, Germany; Department of Radiology, Germany; Division of Experimental Neuroradiology, Germany.

Henning Boecker (H)

University Hospital Bonn, Rheinische Friedrich-Wilhelms-University of Bonn, Germany; Department of Radiology, Germany; Division of Experimental Neuroradiology, Germany.

Dirk Scheele (D)

University Hospital Bonn, Rheinische Friedrich-Wilhelms-University of Bonn, Germany; Department of Psychiatry, Germany; Division of Medical Psychology, Germany.

Rene Hurlemann (R)

University Hospital Bonn, Rheinische Friedrich-Wilhelms-University of Bonn, Germany; Department of Psychiatry, Germany; Division of Medical Psychology, Germany.

Thomas M Kinfe (TM)

University Hospital Bonn, Rheinische Friedrich-Wilhelms-University of Bonn, Germany; Department of Psychiatry, Germany; Division of Medical Psychology, Germany. Electronic address: thomas.kinfe@ukb.uni-bonn.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH